Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Creating content to trigger behaviour change

    White Papers and Resources | July 14, 2022 | Havas Life London

    As part of the development of content and communication strategies in healthcare, we mine for insights into audience behaviours – identifying what HCPs or patients think and how they act;...

    Device Technology and Innovations

    Press Releases | July 14, 2022 | Medscape Education

    The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...

    Infographic: Therapy Watch Lupus

    White Papers and Resources | July 14, 2022 | Inizio

    Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.

    Article: Getting their lives back: Improving options for people with Lupus

    White Papers and Resources | July 14, 2022 | Inizio

    Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

    HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

    Press Releases | July 14, 2022 | Wilmington Healthcare

    Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

    Accelerating patient recruitment post-COVID-19

    White Papers and Resources | July 12, 2022 | Innovative Trials

    COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

    Genesis Research Acquires Market Access Transformation

    Press Releases | July 11, 2022 | Genesis Research Group

    Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

    Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

    Press Releases | July 11, 2022 | Bedrock Healthcare Communications

    The award recognises outstanding achievement in flexing thinking and processes to ensure success.

    ISPOR 2022: a retrospective

    Videos and Podcasts | July 11, 2022 | Genesis Research Group

    Genesis Research – an introduction

    Videos and Podcasts | July 11, 2022 | Genesis Research Group